Home
About
Overview
Sharing Data
ORCID
Help
History (6)
Creatine Kinase, BB Form
Fenbendazole
Minority Health
Torsion, Mechanical
TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study.
See All 6 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study.
TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study. J Clin Oncol. 2011 Apr 01; 29(10):1373-81.
View in:
PubMed
subject areas
Adolescent
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Cytogenetic Analysis
Dioxygenases
Disease-Free Survival
DNA Mutational Analysis
DNA-Binding Proteins
Female
Gene Expression Profiling
Gene Expression Regulation, Leukemic
Genetic Predisposition to Disease
Humans
Kaplan-Meier Estimate
Leukemia, Myeloid, Acute
Male
MicroRNAs
Middle Aged
Mutation
Phenotype
Polymerase Chain Reaction
Proportional Hazards Models
Proto-Oncogene Proteins
Risk Assessment
Risk Factors
Time Factors
Treatment Outcome
United States
Young Adult
authors with profiles
Richard A. Larson